KKR & Co. Inc. posted an “Asset-Based Finance Overview” presentation on its website, available through its Investor Center.
KKR · KKR & Co. Inc.
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
KKR & Co. Inc. appointed Brian J. Lee to its Board effective October 26, 2026, also assigning him to the Audit Committee and Risk Committee; his appointment increased independent directors to eight out of twelve Board seats.
KKR expects to raise over $300 billion from 2024 through 2026, surpass a trillion dollars in AUM within five years, and exceed $15 per share in adjusted net income in 10 years or less.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Net Income non-GAAP | $1.49B | Three Months Ended June 30, 2026 filing | — |
|
|
|||
| Asset Management Segment Earnings non-GAAP | $1.59B | the three months ended June 30, 2026 filing | — |
| Capital Invested | $24.16B | Three months ended June 30, 2026 filing | — |
|
|
|||
| Capital markets debt offerings | 97 | the three months ended June 30, 2026 filing | — |
| Capital markets equity offerings | 15 | the three months ended June 30, 2026 filing | — |
| Capital markets transactions completed | 112 | the three months ended June 30, 2026 filing | — |
| Fee Related Compensation non-GAAP | -$302.04M | Three Months Ended June 30, 2026 filing | — |
| Fee Related Earnings non-GAAP | $1.21B | Three Months Ended June 30, 2026 filing | +36.9% |
|
|
|||
| Fee Related Performance Revenues non-GAAP | $254.7M | Three Months Ended June 30, 2026 filing | — |
| Insurance Operating Earnings non-GAAP | $288.22M | Three Months Ended June 30, 2026 filing | — |
| Management Fees non-GAAP | $1.25B | Three Months Ended June 30, 2026 filing | — |
| Net Realized Investment Income non-GAAP | $191.33M | Three Months Ended June 30, 2026 filing | — |
|
|
|||
| Net Realized Performance Income non-GAAP | $211.88M | Three Months Ended June 30, 2026 filing | — |
|
|
|||
| Other Operating Expenses non-GAAP | -$209.75M | Three Months Ended June 30, 2026 filing | — |
| Realized Investment Income non-GAAP | $189.72M | Three Months Ended June 30, 2026 filing | — |
| Realized Performance Income non-GAAP | $847.54M | Three Months Ended June 30, 2026 filing | — |
| Realized Performance Income Compensation non-GAAP | -$635.65M | Three Months Ended June 30, 2026 filing | — |
| Strategic Holdings Operating Earnings non-GAAP | $37.04M | Three Months Ended June 30, 2026 filing | — |
| Total Investing Earnings non-GAAP | $403.21M | Three Months Ended June 30, 2026 filing | — |
| Total Operating Earnings non-GAAP | $1.54B | Three Months Ended June 30, 2026 filing | — |
|
|
|||
| Total Segment Earnings non-GAAP | $1.94B | Three Months Ended June 30, 2026 filing | — |
|
|
|||
| Transaction and Monitoring Fees, Net non-GAAP | $221.27M | Three Months Ended June 30, 2026 filing | — |
| Adjusted EBITDA non-GAAP | $1.96B | Q2 2026 | — |
| Adjusted Shares non-GAAP | 923,731,511 | Q2 2026 | — |
| Assets Under Management - Credit and Liquid Strategies | $330.83B | Q2 2026 | — |
| Assets Under Management - Private Equity | $254.74B | Q2 2026 | — |
| Assets Under Management - Real Assets | $210.92B | Q2 2026 | — |
| Cash and Investments | $13.93B | Q2 2026 | — |
| Common Stock Outstanding | 897,776,609 | Q2 2026 | — |
| Embedded Gains (Unrealized) in Asset Management | $2.6B | Q2 2026 | — |
| Fee Paying Assets Under Management - Credit and Liquid Strategies | $294.97B | Q2 2026 | — |
| Fee Paying Assets Under Management - Private Equity | $168.14B | Q2 2026 | — |
| Fee Paying Assets Under Management - Real Assets | $175.3B | Q2 2026 | — |
| FRE per Adjusted Share non-GAAP | $1.32 | 2Q'26 | — |
| Global Atlantic Book Value non-GAAP | $11.8B | 2Q'26 | — |
| Gross unrealized carried interest | $10.2B | as of June 30, 2026 | — |
| Investments - Asset Management Segment non-GAAP | $8.61B | 2Q'26 | — |
| K-Series AUM | 42B | 2Q'26 | — |
| Net Cash and Investments | $4.63B | Q2 2026 | — |
| New Capital Raised | 34B | 2Q'26 | — |
| Outstanding Debt (at par) non-GAAP | $9.3B | 2Q'26 | — |
| Perpetual Capital | 334B | 2Q'26 | — |
| Strategic Holdings Segment Earnings non-GAAP | $67.1M | 2Q'26 | — |
| Total Insurance Economics non-GAAP | $515.44M | 2Q'26 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Asset Management — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KKR
this stock
KKR & Co. Inc.
|
$86.16B | -24.7% | -11.0% | — | 0.0% |
|
BLK
BlackRock, Inc.
|
$377.37B | +8.5% | +16.2% | 27.8 | 0.7% |
|
BN
BROOKFIELD Corp
|
$90.72B | -11.4% | — | — | 0.0% |
|
BX
Blackstone Inc.
|
$88.72B | -23.3% | +9.2% | 26.5 | 2.5% |
|
BAM
Brookfield Asset Management Ltd.
|
$81.38B | -2.7% | +21.0% | 29.0 | 1.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KKR | +4.4% | +5.9% | -1.5% | +1.7% | -24.7% |
| SPY | -2.0% | -3.2% | +1.6% | -0.2% | +10.6% |
| vs SPY | +6.4% | +9.1% | -3.1% | +1.9% | -35.3% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.